Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.39 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.29, with a volume of 1,782,919 shares traded.
Northwest Biotherapeutics Trading Up 4.8 %
The business has a 50-day moving average price of $0.31 and a 200-day moving average price of $0.39. The stock has a market cap of $379.54 million, a PE ratio of -3.67 and a beta of -0.58.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last posted its quarterly earnings data on Friday, August 9th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $0.51 million for the quarter.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Texas Roadhouse Stock Steering for New Highs This Year
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Top Stocks Investing in 5G Technology
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
